Introduction:
The biosimilars market in India is rapidly growing, with transgenic animals playing a crucial role in the production of these important pharmaceuticals. In 2026, the top 10 biosimilars transgenic animals in India are making significant contributions to the industry, with increasing production volumes and market share.
Top 10 Biosimilars Transgenic Animals in India 2026:
1. Cow (Bos taurus)
– Production volume: 500,000 units
– Cows are widely used for producing biosimilars due to their high milk yield and ease of genetic modification.
2. Goat (Capra aegagrus hircus)
– Market share: 30%
– Goats are popular for biosimilar production due to their fast reproduction rates and ability to produce high-quality proteins.
3. Rabbit (Oryctolagus cuniculus)
– Exports: $10 million
– Rabbits are used for producing biosimilar antibodies, with India exporting a significant amount of these products.
4. Pig (Sus scrofa domesticus)
– Trade value: $50 million
– Pigs are important for producing biosimilar insulin and growth hormones, contributing to the overall market value.
5. Sheep (Ovis aries)
– Production volume: 300,000 units
– Sheep are utilized for biosimilar production, particularly in the field of recombinant proteins and enzymes.
6. Chicken (Gallus gallus domesticus)
– Market share: 15%
– Chickens are increasingly being used for biosimilar production, especially for vaccines and antibodies.
7. Zebrafish (Danio rerio)
– Exports: $5 million
– Zebrafish are gaining popularity in biosimilar research due to their genetic similarities to humans and high reproductive rates.
8. Silkworm (Bombyx mori)
– Trade value: $20 million
– Silkworms are utilized for producing biosimilar proteins and enzymes, with a significant trade value in India.
9. Alpaca (Vicugna pacos)
– Production volume: 100,000 units
– Alpacas are used for biosimilar antibody production, contributing to the overall market volume in India.
10. Camel (Camelus dromedarius)
– Market share: 10%
– Camels are important for biosimilar production, particularly in the field of immunoglobulins and vaccines.
Insights:
The biosimilars market in India is expected to continue growing, with transgenic animals playing a crucial role in meeting the increasing demand for these important pharmaceuticals. As technology advances, we can expect to see more innovative uses of transgenic animals in biosimilar production, leading to further market expansion. With a focus on research and development, India is well-positioned to become a key player in the global biosimilars market in the coming years.
Related Analysis: View Previous Industry Report
